Compounds > pramipexole
Page last updated: 2024-09-03

pramipexole and Burning Mouth Syndrome

pramipexole has been researched along with Burning Mouth Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cárcamo Fonfría, A; Cuadrado-Pérez, ML; Gómez-Vicente, L; Guerrero Peral, AL; Pedraza, MI; Porta-Etessam, J1
Coon, EA; Laughlin, RS1
Bigal, ME; Rodrigues, GG; Speciali, JG; Stuginski-Barbosa, J1

Other Studies

3 other study(ies) available for pramipexole and Burning Mouth Syndrome

ArticleYear
Burning mouth syndrome: Clinical description, pathophysiological approach, and a new therapeutic option.
    Neurologia (Barcelona, Spain), 2017, Volume: 32, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Burning Mouth Syndrome; Dopamine Agonists; Female; Humans; Middle Aged; Pramipexole

2017
Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause?
    The journal of headache and pain, 2012, Volume: 13, Issue:3

    Topics: Aged; Antiparkinson Agents; Benzothiazoles; Burning Mouth Syndrome; Carbidopa; Dopamine; Dopamine Agonists; Drug Combinations; Female; Humans; Levodopa; Parkinson Disease; Pramipexole

2012
Burning mouth syndrome responsive to pramipexol.
    The journal of headache and pain, 2008, Volume: 9, Issue:1

    Topics: Aged; Benzothiazoles; Burning Mouth Syndrome; Corpus Striatum; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Female; Humans; Mouth Mucosa; Parkinson Disease; Pramipexole; Prospective Studies; Receptors, Dopamine D2; Restless Legs Syndrome; Substance Withdrawal Syndrome; Treatment Outcome

2008